Ethics declarations Conflict of interest F.C.S declares grants from NIH/NIDDK (P30 DK040561, U24 DK132733, and UE5 DK137285) and consulting fees from Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, AstraZeneca, AbbVie, Currax, Pfizer, Doximity, MelliCell, Vida Health, Empros Pharma, Apnimed, Clearmind Medicine, and Ilant Health, all outside of the current work
It summarizes publicly available company disclosures and ingredient-level research for informational purposes only
Metabolic surgery triggers a complex cascade of hormonal and metabolic changes that influence hunger, satiety and fat metabolism
The treatment plan depends on clinical goals: sleep/anxiety, vasomotor symptoms, libido, bone health, and more
Foundayo produced 12.4% at the highest dose over 72 weeks
Symptoms can include severe abdominal pain, nausea and vomiting